Because IL-9 was not affecting melanoma or lung carcinoma cell proliferation in vitro, Purwar and colleagues have investigated whether host immune cells were responsible for the anti-cancer effect of IL-9 in vivo. The gene discussed is IL9; the disease is lung carcinoma.